Short interest in CytoMed Therapeutics Ltd (NASDAQ:GDTC) decreased during the last reporting period, falling from 116.08K to 95.34K. This put 5.59% of the company's publicly available shares short.

Short interest for CytoMed Therapeutics gives investors a sense of the degree to which investors are betting on the decline of CytoMed Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 27.66K shares traded per day, it would take 3.45 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.